Renal dose dopamine--it's myth and the truth.

Simple item page
dc.contributor.authorPadmanabhan, Ren_US
dc.date.accessioned2002-04-08en_US
dc.date.accessioned2009-05-31T01:29:52Z
dc.date.available2002-04-08en_US
dc.date.available2009-05-31T01:29:52Z
dc.date.issued2002-04-08en_US
dc.description35 references.en_US
dc.description.abstractRenal dose dopamine is prescribed worldwide for the prevention and treatment of acute renal failure. It's use is based on selective renal vasodilatation (induced at low doses) observed in animal studies and normal subjects. But most clinical studies have failed to demonstrate convincingly the benefit of low dose dopamine in acute renal failure. Moreover adverse effects of dopamine have been recognised warranting its use only in specific situations where benefit is proved. The available data on renal dose dopamine are either poor or statistically underpowered to draw conclusion. Therefore, a prospective, controlled trial with adequate patient number is required, to confirm the benefits.en_US
dc.description.affiliationDepartment of Nephrology, Government Royapettah Hospital, Chennai.en_US
dc.identifier.citationPadmanabhan R. Renal dose dopamine--it's myth and the truth. Journal of the Association of Physicians of India. 2002 Apr; 50(): 571-5en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/92224
dc.language.isoengen_US
dc.source.urihttps://www.japi.orgen_US
dc.subject.meshAnimalsen_US
dc.subject.meshDopamine --administration & dosageen_US
dc.subject.meshHumansen_US
dc.subject.meshKidney Failure, Acute --drug therapyen_US
dc.subject.meshRenal Artery --drug effectsen_US
dc.subject.meshRisk Factorsen_US
dc.subject.meshVasodilation --drug effectsen_US
dc.titleRenal dose dopamine--it's myth and the truth.en_US
dc.typeJournal Articleen_US
dc.typeReviewen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Journal of the Association of Physicians of India